Ad is loading...
IVGSX
Price
$23.38
Change
-$0.17 (-0.72%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

IVGSX vs VIVAX

Header iconIVGSX vs VIVAX Comparison
Open Charts IVGSX vs VIVAXBanner chart's image
VY® Invesco Growth and Income S
Price$23.38
Change-$0.17 (-0.72%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
IVGSX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVGSX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGSX is a StrongBuy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. IVGSX (162M). VIVAX pays higher dividends than IVGSX: VIVAX (2.25) vs IVGSX (1.55). IVGSX was incepted earlier than VIVAX: IVGSX (31 years) vs VIVAX (32 years). IVGSX has a lower initial minimum investment than VIVAX: IVGSX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 25.55 vs. IVGSX (16.13). VIVAX return over 5 years is better than : 50.81 vs. IVGSX (12.68).
IVGSXVIVAXIVGSX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years32 years-
Gain YTD7.68917.91243%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets162M184B0%
Annual Yield % from dividends1.552.2569%
Returns for 1 year16.1325.5563%
Returns for 3 years-9.0221.58-42%
Returns for 5 years12.6850.8125%
Returns for 10 years-10.31110.46-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POR46.650.76
+1.66%
Portland General Electric Company
UMH19.16-0.17
-0.85%
UMH Properties
YQ1.86-0.02
-1.11%
17 Education & Technology Group
FICO2261.00-62.17
-2.68%
Fair Isaac Corp
PSTX2.76-0.45
-14.02%
Poseida Therapeutics